BECTON DICKINSON's PURCHASE OF OHMEDA MEDICAL DEVICE DIVISION WILL ADD $140 MIL. IN ANNUAL EUROPEAN REVENUES; $425 MIL. CASH DEAL IS FIRM's LARGEST EVER
This article was originally published in The Gray Sheet
Becton Dickinson will substantially increase the sales of its I.V. catheters and critical care products in Europe with the purchase of Ohmeda's medical devices division (MDD) from BOC Group. Last year, about $140 mil. of the unit's $200 mil. in revenues were generated Europe.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.